• SENSEX 80,643.74
    1,333.73 (+1.68%)
  • BANKNIFTY 57,773.65
    1,860.05 (+3.33%)
Back

Corporate News

Ennature Bio Pharma to review Q2 financial results at board meeting November 12
05-Nov-2026, 05:08

Ennature Bio Pharma Limited will hold a board meeting on Thursday, November 12, 2026, to consider and approve the unaudited financial results for the second quarter ended September 30, 2026, according to a regulatory filing with the BSE Limited and National Stock Exchange of India Limited. The company’s trading window will remain closed from Wednesday, November 4, 2026, to Saturday, November 14, 2026, as previously announced.